Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study
Rheumatol Ther. 2021;8(2):903–919
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatol Ther. 2021;8(2):903–919
Ann Rheum Dis. 2021 May 28. DOI: 10.1136/annrheumdis-2021-220418
Clin Rheumatol. 2021 Jun 16. DOI: 10.1007/s10067-021-05815-3
Clin Exp Rheumatol. 2021;39(3):668-675.
RMD Open. 2021;7(2):e001601.
Rheumatology (Oxford). 2021;60(5):2256-2266.
Wells AF, et al. Rheumatol Ther. 2021. Epub ahead of print. DOI: 10.1007/s40744-021-00317-9.
Int J Clin Pharmacol Ther. 2021. Epub ahead of print.
Arthritis Care Res (Hoboken). 2021;73(4):481-488.
Rheumatology (Oxford). 2021;60(4):1708-1716.